Metropolis Healthcare Ltd's Q4FY25 Quarter Results
- 14 May 2025
Result Summary
- Metropolis Healthcare Ltd reported a 2.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 17.5%.
- Its expenses for the quarter were up by 0.0% QoQ and 17.0% YoY.
- The net profit increased 16.1% QoQ and increased 9.1% YoY.
- The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 7.1 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 333.54 | 325.32 | 283.77 | 2.5% | 17.5% |
Total Expenses | 283.01 | 282.99 | 241.86 | 0.0% | 17.0% |
Profit Before Tax | 50.53 | 42.34 | 41.90 | 19.3% | 20.6% |
Tax | 14.01 | 10.86 | 8.41 | 29.0% | 66.6% |
Profit After Tax | 36.53 | 31.47 | 33.49 | 16.1% | 9.1% |
Earnings Per Share | 7.10 | 6.10 | 6.50 | 16.4% | 9.2% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Metropolis Healthcare Ltd is a prominent player in the healthcare sector, primarily known for providing pathology and diagnostic services. The company operates a network of diagnostic laboratories and service centers, offering a comprehensive range of tests and health checkup packages. Metropolis Healthcare is well-regarded for its commitment to quality and accuracy in diagnostics, serving both individual patients and healthcare providers. As of the latest available data, the company continues to expand its presence in domestic and international markets, focusing on enhancing its technological capabilities and service offerings. No specific recent major developments are available from the provided data.
Revenue
In the fourth quarter of fiscal year 2025 (Q4FY25), Metropolis Healthcare Ltd reported a total income of ₹333.54 crores. This marks a quarter-over-quarter (QoQ) increase of 2.5% from ₹325.32 crores in Q3FY25, and a year-over-year (YoY) increase of 17.5% from ₹283.77 crores in Q4FY24. The growth in total income indicates a robust performance over both quarterly and annual periods. This revenue is primarily driven by the company's extensive range of diagnostic services, which cater to a wide demographic of patients and institutions.
Profitability
In terms of profitability, Metropolis Healthcare Ltd's profit before tax in Q4FY25 was ₹50.53 crores, reflecting a significant QoQ increase of 19.3% from ₹42.34 crores in Q3FY25 and a YoY increase of 20.6% from ₹41.90 crores in Q4FY24. The tax expenses for Q4FY25 amounted to ₹14.01 crores, showing a substantial rise of 29.0% QoQ and 66.6% YoY, from ₹10.86 crores and ₹8.41 crores respectively. Profit after tax stood at ₹36.53 crores, a QoQ growth of 16.1% and a YoY increase of 9.1%. The earnings per share (EPS) for Q4FY25 was ₹7.10, up by 16.4% QoQ and 9.2% YoY, indicating an improvement in shareholder returns over the reported periods.
Operating Metrics
The total expenses for Metropolis Healthcare Ltd in Q4FY25 were ₹283.01 crores, showing a marginal increase from ₹282.99 crores in Q3FY25, with no significant QoQ change (0.0%). However, on a YoY basis, total expenses rose by 17.0% from ₹241.86 crores in Q4FY24. This indicates that the company managed its costs effectively while achieving income growth. The operating performance, as reflected in the consistent increase in income and profitability metrics, demonstrates the company's ability to maintain steady operations and manage its resources efficiently. The consistent rise in tax expenses also reflects the growing profitability of the company.